Verastem, inc. (VSTM)
Income statement / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11
Revenue:
Total revenue

20,841

17,456

15,049

21,525

28,389

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Operating expenses:
Cost of sales - product

1,575

1,238

1,022

700

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cost of sales - intangible amortization

1,569

1,569

1,568

1,207

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Research and development

46,944

45,778

42,085

41,437

42,472

43,648

46,139

52,311

48,972

46,423

42,062

28,535

23,985

19,779

20,575

27,663

34,216

40,565

42,562

40,305

37,565

35,448

33,563

31,305

29,045

25,930

22,224

23,567

22,205

21,712

22,018

16,968

14,011

9,883

0

0

0

Selling, general and administrative

94,783

101,212

103,683

106,956

93,471

77,265

56,460

0

0

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total operating expenses

144,871

149,797

148,358

150,300

137,081

121,501

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

General and administrative

-

-

-

-

-

-

-

-

-

21,381

-

17,939

17,731

17,223

16,588

16,975

17,175

17,634

17,674

17,785

18,150

18,159

17,439

16,953

16,410

15,472

15,761

14,204

12,178

10,518

8,256

6,923

5,469

3,815

0

0

0

Total operating expenses

-

-

-

-

-

-

-

-

-

67,804

61,552

46,474

41,716

37,002

37,163

44,638

51,391

58,199

60,236

58,090

55,715

53,607

51,002

48,258

45,455

41,402

37,985

37,771

34,383

32,230

30,274

23,891

19,480

13,698

0

0

0

Loss from operations

-124,030

-132,341

-133,309

-128,775

-108,692

-94,783

-78,576

-80,144

-75,417

-67,804

-61,552

-46,474

-41,716

-37,002

-37,163

-44,638

-51,391

-58,199

-60,236

-58,090

-55,715

-53,607

-51,002

-48,258

-45,455

-41,402

-37,985

-37,771

-34,383

-32,230

-30,274

-23,891

-19,480

-13,698

0

0

0

Other expense

0

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Interest income

3,240

4,381

5,076

4,834

3,909

2,603

1,442

800

597

561

561

577

577

562

515

467

412

334

285

252

232

242

262

259

228

200

186

196

233

246

206

0

0

0

-

-

-

Interest expense

26,353

20,608

19,107

14,928

10,259

5,810

2,186

1,434

1,027

559

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accretion of preferred stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

32

0

0

0

Net loss

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-57,865

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-13,715

0

0

0

Net loss

-149,097

-149,209

-121,784

-113,313

-89,486

-72,434

-79,320

-80,778

-75,847

-67,802

-61,222

-46,018

-41,151

-36,440

0

0

0

-

-

-

-

-53,365

-50,740

-47,999

-45,227

-41,202

-37,799

-37,575

-34,150

-31,984

-30,068

-23,748

-19,408

-13,683

0

0

0

Net loss per share—basic (in shares)

-

76,331

74,228

73,877

-

73,766

73,644

61,256

50,835

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net loss per share—diluted (in shares)

-

76,331

74,228

73,877

-

91,061

73,644

61,256

50,835

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net loss per share—basic and diluted

-0.35

-

-0.40

-0.57

-0.52

-

-

-

-

-0.43

-0.61

-0.36

-0.35

-0.32

-0.21

-0.23

-0.22

-0.32

-0.42

-0.42

-0.46

-0.53

-0.52

-0.51

-0.51

-0.45

-0.44

-0.49

-0.44

-0.39

-0.51

-0.34

-0.47

-4.01

-2.98

-2.03

-1.06

Net loss per share—basic

-

-0.51

-0.41

-0.57

-

-0.15

-0.29

-0.30

-0.41

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net loss per share—diluted

-

-0.51

-0.41

-0.57

-

-0.37

-0.29

-0.30

-0.41

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Weighted average common shares outstanding used in computing:
Weighted average common shares outstanding used in computing net loss per share - basic and diluted

108,153

-

74,234

73,876

73,854

-

-

-

-

42,027

37,630

36,992

36,992

36,992

36,992

36,992

36,975

36,935

36,898

36,522

33,323

26,248

25,811

25,669

25,478

25,277

24,127

20,729

20,483

20,309

20,160

19,863

14,693

1,500

1,361

1,225

1,089

Net loss

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-57,865

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-13,715

0

0

0

Net loss

-149,097

-149,209

-121,784

-113,313

-89,486

-72,434

-79,320

-80,778

-75,847

-67,802

-61,222

-46,018

-41,151

-36,440

0

0

0

-

-

-

-

-53,365

-50,740

-47,999

-45,227

-41,202

-37,799

-37,575

-34,150

-31,984

-30,068

-23,748

-19,408

-13,683

0

0

0

Unrealized (loss) gain on available-for-sale securities

-101

-113

0

0

0

-

-

-

-

-31

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Comprehensive loss

-149,198

-149,322

0

0

0

-

-

-

-

-67,833

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-13,685

0

0

0

Product revenue, net
Total revenue

15,702

12,339

9,932

6,408

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

License and collaboration revenue
Total revenue

0

-

0

0

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-